Derivative containing glucosamine and nitrile pyridine structure and use thereof

A technology for diabetes drugs and products, which is applied in the preparation of sugar derivatives, sugar derivatives, and sugar derivatives, etc., can solve the problems of unclear exact causes, loss of sensitivity, and decreased insulin secretion-stimulating effect.
CN104628795AInactive Publication Date: 2015-05-20FOSHAN SAIWEISI MEDICINE SCI & TECH
3 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
FOSHAN SAIWEISI MEDICINE SCI & TECH
Publication Date
2015-05-20
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to the field of drugs associated with Type II diabetes and particularly relates to a GPR119 agonist containing glucosamine and a nitrile pyridine structure shown in the specification as well as a preparation method thereof and an application of the GPR119 agonist in preparation of Type II diabetes drugs.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The present invention relates to the pharmaceutical field for the treatment of type II diabetes. More specifically, the present invention relates to a GPR119 agonist containing glucosamine and cyanopyridine structure, which has a therapeutic effect on type II diabetes, its preparation method, and its application in pharmacy. Background technique

[0002] Diabetes is increasingly threatening human health. In the United States today, approximately 16 million people are suffering from diabetes. Type 1 diabetes, also known as insulin-dependent diabetes, is an autoimmune disease. It is caused by the destruction of the pancreatic islet β cells that can produce insulin by the autoimmune system. There is currently no cure for this disease in the world, so patients must receive insulin injections. Without insulin injections, cells cannot absorb glucose for energy. Symptoms associated with type 1 diabetes usually appear in childhood and adolescence. Because...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More